CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules

Leukemia

Volumn 11, Issue 4, 1997, Pages 572-580

  Van Den Hove, L E ^a   Van Gool, S W ^a   Vandenberghe, P ^b   Bakkus, M ^c   Thielemans, K ^c   Boogaerts, M A ^b   Ceuppens, J L ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

B CLL; CD40; CD40L; CD80; CD86; Costimulation

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 39; MONOCLONAL ANTIBODY;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030989818     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400598     Document Type: Article

References (10)

1. Foerster J. Chronic lymphocytic leukemia. In: Lee CR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds). Wintrobe's Clinical Hematology, 9th edn. Lea & Febiger: Philadelphia, London, 1993, pp 2034-2053.
2. Montserrat E, Rozman C. Chronic lymphocytic leukemia: present status. Ann Oncol 1995; 6: 219-235.
3. Talpaz M, Rosenblum M, Kurzrock R, Reuben J, Kantarjian H, Guttermann J. Clinical and laboratory changes induced by alpha Interferon in chronic lymphocytic leukemia - a pilot study. Am J Hematol 1987; 24: 341-350.
4. Rozman C, Montserrat E, Vinolas N, Urbano-Ispizua A, Ribera JM, Gallart T, Compernolle C. Recombinant α2-interferon in the treatment of B chronic lymphocytic leukemia in early stages. Blood 1988; 71: 1295-1298.
5. Sherman W, Liu Z, Inghirami G, Reed EF, Harris PE, Suciu-Foca NM. Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T-cells. Immunol Res 1993; 12: 338-348.
6. Farace F, Orlanducci F, Dietrich P-Y, Gaudin C, Angevin E, Courtier M-H, Bayle C, Hercend T, Triebel F. T cell repertoire in patients with B chronic lymphocytic leukemia. J Immunol 1994; 153: 4281-4290.
7. Ostrand-Rosenberg S. Tumor immunotherapy: the tumor as an antigen-presenting cell. Curr Opin Immunol 1994; 6: 722-727.
8. Wolos JA, Davey FR. Depressed stimulation in the MLR by B lymphocytes in chronic lymphocytic leukemia: failure to demonstrate a suppressor cell. Clin Immunol Immunopathol 1979; 14: 77-85.
9. Dazzi F, D'Andrea E, Biasi G, De Silvestro G, Gaidano G, Schena M, Tison T, Vianello F, Girolami A, Caligaris-Cappio F. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol 1995; 75: 26-32.
10. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445-480.